Rare diseases
Investigational molecules
Locations
Back to France3 418 clinical trials in Clichy, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer
FranceStudy Comparing MK-4280A (Favezelimab and Pembrolizumab) with Chemotherapy for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma
FranceStudy on SOT102 for Patients with Advanced Gastric and Pancreatic Cancer, Alone or with Drug Combination
FranceStudy of Regorafenib with Chemotherapy for Newly Diagnosed Patients with Metastatic Ewing Sarcoma
FranceStudy on the Safety and Effectiveness of SerpinPC for Patients with Hemophilia B with Inhibitors
FranceStudy of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery
FranceStudy of Pembrolizumab, Paclitaxel, and Bevacizumab for Patients with Platinum-Resistant Recurrent Ovarian Cancer
FranceStudy of Radiotherapy with Cetuximab and Xevinapant for Patients with Advanced Head and Neck Cancer Unfit for High-Dose Cisplatin
FranceStudy of Pembrolizumab and Lenvatinib for Patients with Advanced Non-Clear Cell Kidney Cancer
FranceStudy of Olaparib and Pembrolizumab for Patients with Advanced Cancer with HRRm or HRD Mutations
FranceStudy on Rifaximin for Delaying Hepatic Encephalopathy in Cirrhosis Patients
FranceStudy to Determine Safe Doses of Selexipag for Children with Pulmonary Arterial Hypertension
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on inflammatory bowel diseases and advanced treatment methods, including studies on Crohn's disease and ulcerative colitis using fecal microbiota transplantation as therapeutic approaches.
Research aims to improve patient outcomes through novel therapeutic interventions and treatment strategies.
Comprehensive studies on liver diseases and biliary tract conditions, investigating new treatments for cirrhosis, portal hypertension, and various forms of liver cancer.
Advanced therapeutic approaches combining immunotherapy and targeted treatments.
Groundbreaking research on pancreatic cancer and metabolic conditions, evaluating novel drug combinations and treatment protocols.
Focus on improving survival rates and treatment efficacy in advanced-stage diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
